Impact of nutrition counseling on anthropometry and dietary intake of multiple sclerosis patients at Kasr Alainy Multiple Sclerosis Unit, Cairo, Egypt 2019-2020: randomized controlled clinical trial

被引:6
|
作者
Afifi, Zeinab [1 ]
Hassan, Amr [2 ]
Abdelrahman, Nebal [3 ]
El Sayed, Asmaa [1 ]
Salem, Marwa [1 ]
机构
[1] Cairo Univ, Fac Med, Dept Publ Hlth & Community Med, Cairo, Egypt
[2] Cairo Univ, Fac Med, Dept Neurol, Cairo, Egypt
[3] Natl Nutr Inst, Dept Clin Nutr, Cairo, Egypt
关键词
Multiple sclerosis; Randomized controlled clinical trial; Nutrition counseling; Overweight; obesity; Macronutrients; Micronutrients; DISABILITY;
D O I
10.1186/s13690-022-01013-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundFaulty dietary habits and overnutrition are prevalent among Egyptian patients with multiple sclerosis (MS) who do not receive nutrition care as part of treatment. Thus, this study was conducted to identify the effect of nutrition counseling on the nutritional status of patients with MS. This endeavor might provide evidence for the value of counseling in such a setting and advance the integration of nutrition counseling into the routine management of patients with MS.MethodsA single-blinded, parallel-randomized controlled clinical trial was conducted at Kasr Alainy MS Unit on 120 eligible patients with MS from September 2019 to February 2020. Patients were randomly allocated to either the nutrition counseling intervention group (IG) or the control group (CG). Allocation concealment was performed by using sequentially numbered opaque sealed envelopes. All patients were assessed initially and complied with the Kasr Alainy MS Unit standard management protocol for the study period. Only patients in the IG underwent initial nutrition counseling sessions followed by a monthly evaluation. All patients were assessed at the end of the 3-month follow-up period. Sociodemographic data were gathered through a structured interview. Nutritional status was assessed anthropometrically and via 24-h recall. The 2 groups were compared initially and at the end of the follow-up. Both intention-to-treat and per-protocol analyses were conducted.ResultsAt baseline assessment, the prevalence of overweight and obesity was 31.7% and 32.5%, respectively, and the mean body mass index was 27.7 +/- 5.7 kg/m(2). Mean waist circumference was 93.5 +/- 11.9 and 99.2 +/- 13.1 cm for males and females, respectively. Approximately 27.3% of males and 83.9% of females showed abdominal obesity. After 3 months of counseling, weight, body mass index, waist circumference, nutrient intake and adequacy significantly improved in the IG (p < 0.05).ConclusionNutrition counseling significantly improved anthropometric measurements, dietary habits, nutrient intake and adequacy.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Effectiveness of mindfulness-integrated cognitive behavior therapy on anxiety, depression and hope in multiple sclerosis patients: a randomized clinical trial (vol 42, pg 55, 2020)
    Pouyanfard, Sahar
    Mohammadpour, Mohsen
    ParviziFard, Ali A.
    Sadeghi, Kheirollah
    TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY, 2020, 42 (02) : 216 - 216
  • [42] Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial
    Giancarlo Coghe
    Federica Corona
    Elisabetta Marongiu
    Giuseppe Fenu
    Jessica Frau
    Lorena Lorefice
    Antonio Crisafulli
    Manuela Galli
    Alberto Concu
    Maria Giovanna Marrosu
    Massimiliano Pau
    Eleonora Cocco
    Journal of Neurology, 2018, 265 : 1328 - 1333
  • [43] Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial
    Coghe, Giancarlo
    Corona, Federica
    Marongiu, Elisabetta
    Fenu, Giuseppe
    Frau, Jessica
    Lorefice, Lorena
    Crisafulli, Antonio
    Galli, Manuela
    Concu, Alberto
    Marrosu, Maria Giovanna
    Pau, Massimiliano
    Cocco, Eleonora
    JOURNAL OF NEUROLOGY, 2018, 265 (06) : 1328 - 1333
  • [44] Effect of Cognitive-Behavioral Group Therapy on Pain Self-efficacy, Fatigue, Life Expectancy and Depression in Patients With Multiple Sclerosis: A Randomized Controlled Clinical Trial
    Shareh, Hossein
    Robati, Zahra
    IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, 2021, 26 (04): : 418 - 431
  • [45] The effect of crocin-selenium nanoparticles on the cognition and oxidative stress markers of multiple sclerosis patients: a randomized triple-blinded placebo-controlled clinical trial
    Nasim Rezaeimanesh
    Pegah Rafiee
    Roghayyeh Saeedi
    Pegah Khosravian
    Mohammad Ali Sahraian
    Sharareh Eskandarieh
    Abdorreza Naser Moghadasi
    Soodeh Razeghi Jahromi
    BioMetals, 2024, 37 : 305 - 319
  • [46] The effect of crocin-selenium nanoparticles on the cognition and oxidative stress markers of multiple sclerosis patients: a randomized triple-blinded placebo-controlled clinical trial
    Rezaeimanesh, Nasim
    Rafiee, Pegah
    Saeedi, Roghayyeh
    Khosravian, Pegah
    Sahraian, Mohammad Ali
    Eskandarieh, Sharareh
    Moghadasi, Abdorreza Naser
    Jahromi, Soodeh Razeghi
    BIOMETALS, 2024, 37 (02) : 305 - 319
  • [47] Impact of supplementation with "multivitamin-mineral" specially formulated to improve fatigue and inflammatory state in patients with multiple sclerosis: A triple-blind, randomized, placebo-controlled trial
    Bitarafan, Sama
    Karimi, Elmira
    Moghadasi, Abdorreza Naser
    Kazemi-Mozdabadi, Razieh Sadat K.
    Mohammadpour, Zinat
    Sahraian, Mohammad Ali
    CURRENT JOURNAL OF NEUROLOGY, 2020, 19 (04): : 180 - 189
  • [48] Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report
    Arreola-Mora, C.
    Silva-Pereyra, J.
    Fernandez, T.
    Paredes-Cruz, M.
    Bertado-Cortes, B.
    Grijalva, I
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 117 - 124
  • [49] Clinical results from AFFIRM: A randomized, double-blind, placebo-controlled, multicenter trial to determine the efficacy and safety of natalizumab in patients with relapsing multiple sclerosis (MS)
    Polman, C
    O'Connor, P
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, D
    Phillips, JT
    Lublin, F
    Giovannoni, G
    Wajgt, A
    Lynn, F
    Toal, M
    Panzara, M
    NEUROLOGY, 2005, 64 (06) : A146 - A146
  • [50] The effect of peer education based on Pender's health promotion model on quality of life, stress management and self-efficacy of patients with multiple sclerosis: a randomized controlled clinical trial
    Bijani, Mostafa
    Niknam, Maryam
    Karimi, Shanaz
    Naderi, Zeinab
    Dehghan, Azizallah
    BMC NEUROLOGY, 2022, 22 (01)